BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16894454)

  • 1. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study.
    Bova C; Marchiori A; Noto A; Rossi V; Daniele F; Santoro C; Ricchio R; De Lorenzo R; Umbaca R; Prandoni P
    Thromb Haemost; 2006 Aug; 96(2):132-6. PubMed ID: 16894454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
    Ageno W; Becattini C; Brighton T; Selby R; Kamphuisen PW
    Circulation; 2008 Jan; 117(1):93-102. PubMed ID: 18086925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
    Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
    Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Links between arterial and venous disease.
    Prandoni P
    J Intern Med; 2007 Sep; 262(3):341-50. PubMed ID: 17697155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
    Chew HK; Wun T; Harvey DJ; Zhou H; White RH
    J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
    Mahmoodi BK; ten Kate MK; Waanders F; Veeger NJ; Brouwer JL; Vogt L; Navis G; van der Meer J
    Circulation; 2008 Jan; 117(2):224-30. PubMed ID: 18158362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics, and effect of raloxifene.
    Duvernoy CS; Kulkarni PM; Dowsett SA; Keech CA
    Menopause; 2005; 12(4):444-52. PubMed ID: 16037760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study.
    Bank I; van de Poel MH; Coppens M; Hamulyák K; Prins MH; van der Meer J; Veeger NJ; Büller HR; Middeldorp S
    Thromb Haemost; 2007 Nov; 98(5):1040-4. PubMed ID: 18000609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study.
    Gatt ME; Paltiel O; Bursztyn M
    Thromb Haemost; 2004 Mar; 91(3):538-43. PubMed ID: 14983230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
    Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
    Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.
    Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J
    Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The occurrence of occult malignancy in patients less than 50 years of age with venous thromboembolism: which diagnostic screening methods to use?].
    Malý R; Vodicková L
    Vnitr Lek; 2004 Oct; 50(10):751-5. PubMed ID: 15633930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.